Prescription drug · ANDA
Levothyroxine sodium NDC 71205-642
Levothyroxine sodium 100 ug/1 · Tablet · Oral · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71205-642-30 | 71205064230 | 30 TABLET in 1 BOTTLE (71205-642-30)Marketed from Mar 10, 2022 | |
| 71205-642-60 | 71205064260 | 60 TABLET in 1 BOTTLE (71205-642-60)Marketed from Mar 10, 2022 | |
| 71205-642-90 | 71205064290 | 90 TABLET in 1 BOTTLE (71205-642-90)Marketed from Mar 10, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Levothyroxine sodium
- Generic name (nonproprietary)
- levothyroxine sodium
- Active ingredients
- Levothyroxine sodium — 100 ug/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Proficient Rx LPNDC labeler code 71205
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 212399
- Marketing start
- Listing expires
- Other FDA classes
- Thyroxine (Chemical structure)
- Identifiers
- Product ID 71205-642_7a6abcab-a753-4c1d-92fb-c134ffc2c0a7SPL ID 7a6abcab-a753-4c1d-92fb-c134ffc2c0a7SPL set ID 9d1aaa2d-c8c0-478f-8540-f92f6512cfcbRxCUI 892246UNII 9J765S329GUPC 0371205642907
- Pharmacologic class
- l-Thyroxine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471205064230followed by a unit qualifier and the quantityPackage 71205-0642-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Hypothyroidism Levothyroxine sodium tablets are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid ‑ Stimulating Hormone, TSH) Suppression Levothyroxine sodium tablets are indicated as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. • Limitations of Use: • Levothyroxine sodium tablets are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with levothyroxine sodium may induce h…
Excerpt only. Read the full label for complete information.
About NDC 71205-642
- What is NDC 71205-642?
- 71205-642 is the product NDC for Levothyroxine sodium, Levothyroxine sodium 100 ug/1 tablet, listed with the FDA by Proficient Rx LP. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Levothyroxine sodium.
- What is the active ingredient?
- Levothyroxine sodium.
- Who is the labeler?
- Proficient Rx LP, NDC labeler code 71205. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Levothyroxine sodium?
- 521 other product NDCs are listed under this name. See all Levothyroxine sodium NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Levothyroxine sodium products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine sodium .05 mg/1 | TabletOral | Coupler LLC | 67046-0819 | 67046-0819-03 |
| Levothyroxine Sodium | Levothyroxine sodium .137 mg/1 | TabletOral | Coupler LLC | 67046-0972 | 67046-0972-03 |
| Levothyroxine Sodium | Levothyroxine sodium .2 mg/1 | TabletOral | Coupler LLC | 67046-0387 | 67046-0387-03 |
| Levothyroxine Sodium | Levothyroxine sodium .125 mg/1 | TabletOral | Coupler LLC | 67046-0951 | 67046-0951-03 |
| Levothyroxine Sodium | Levothyroxine sodium 100 ug/1 | TabletOral | Coupler LLC | 67046-1679 | 67046-1679-03 |
| Levothyroxine Sodium | Levothyroxine sodium .175 mg/1 | TabletOral | Coupler LLC | 67046-0517 | 67046-0517-03 |
| Levothyroxine Sodium | Levothyroxine sodium .15 mg/1 | TabletOral | Coupler LLC | 67046-0515 | 67046-0515-03 |
| Levothyroxine Sodium | Levothyroxine sodium .1 mg/1 | TabletOral | Coupler LLC | 67046-0569 | 67046-0569-03 |
| Levothyroxine Sodium | Levothyroxine sodium .075 mg/1 | TabletOral | Coupler LLC | 67046-0801 | 67046-0801-03 |
| Levothyroxine Sodium | Levothyroxine sodium .112 mg/1 | TabletOral | Coupler LLC | 67046-0290 | 67046-0290-03 |
Other NDCs under ANDA 212399
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Levothyroxine sodium | Levothyroxine sodium 25 ug/1 | TabletOral | Accord Healthcare Inc. | 16729-447 |
| Levothyroxine sodium | Levothyroxine sodium 50 ug/1 | TabletOral | Accord Healthcare Inc. | 16729-448 |
| Levothyroxine sodium | Levothyroxine sodium 75 ug/1 | TabletOral | Accord Healthcare Inc. | 16729-449 |
| Levothyroxine sodium | Levothyroxine sodium 88 ug/1 | TabletOral | Accord Healthcare Inc. | 16729-450 |
| Levothyroxine sodium | Levothyroxine sodium 100 ug/1 | TabletOral | Accord Healthcare Inc. | 16729-451 |
| Levothyroxine sodium | Levothyroxine sodium 112 ug/1 | TabletOral | Accord Healthcare Inc. | 16729-452 |
| Levothyroxine sodium | Levothyroxine sodium 125 ug/1 | TabletOral | Accord Healthcare Inc. | 16729-453 |
| Levothyroxine sodium | Levothyroxine sodium 137 ug/1 | TabletOral | Accord Healthcare Inc. | 16729-454 |
| Levothyroxine sodium | Levothyroxine sodium 150 ug/1 | TabletOral | Accord Healthcare Inc. | 16729-455 |
| Levothyroxine sodium | Levothyroxine sodium 175 ug/1 | TabletOral | Accord Healthcare Inc. | 16729-456 |
| Levothyroxine sodium | Levothyroxine sodium 200 ug/1 | TabletOral | Accord Healthcare Inc. | 16729-457 |
| Levothyroxine sodium | Levothyroxine sodium 300 ug/1 | TabletOral | Accord Healthcare Inc. | 16729-458 |
| Levothyroxine sodium | Levothyroxine sodium 88 ug/1 | TabletOral | A-S Medication Solutions | 50090-6087 |
| Levothyroxine sodium | Levothyroxine sodium 137 ug/1 | TabletOral | A-S Medication Solutions | 50090-6089 |
| Levothyroxine sodium | Levothyroxine sodium 50 ug/1 | TabletOral | A-S Medication Solutions | 50090-6090 |
| Levothyroxine sodium | Levothyroxine sodium 125 ug/1 | TabletOral | A-S Medication Solutions | 50090-6100 |
| Levothyroxine sodium | Levothyroxine sodium 100 ug/1 | TabletOral | A-S Medication Solutions | 50090-6101 |
| Levothyroxine sodium | Levothyroxine sodium 112 ug/1 | TabletOral | A-S Medication Solutions | 50090-6103 |
| Levothyroxine sodium | Levothyroxine sodium 150 ug/1 | TabletOral | A-S Medication Solutions | 50090-6104 |
| Levothyroxine sodium | Levothyroxine sodium 200 ug/1 | TabletOral | A-S Medication Solutions | 50090-6105 |
Showing 20 of 40.